787 related articles for article (PubMed ID: 24285561)
21. Clinical profile and outcome of patients with severe aortic stenosis at high surgical risk: single-center prospective evaluation according to treatment assignment.
Dvir D; Sagie A; Porat E; Assali A; Shapira Y; Vaknin-Assa H; Shafir G; Bental T; Nevzorov R; Battler A; Kornowski R
Catheter Cardiovasc Interv; 2013 Apr; 81(5):871-81. PubMed ID: 22915555
[TBL] [Abstract][Full Text] [Related]
22. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
[TBL] [Abstract][Full Text] [Related]
23. Balloon-expandable prostheses for transcatheter aortic valve replacement.
Ribeiro HB; Urena M; Allende R; Amat-Santos IJ; Rodés-Cabau J
Prog Cardiovasc Dis; 2014; 56(6):583-95. PubMed ID: 24838134
[TBL] [Abstract][Full Text] [Related]
24. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
[TBL] [Abstract][Full Text] [Related]
25. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.
Durand E; Eltchaninoff H; Canville A; Bouhzam N; Godin M; Tron C; Rodriguez C; Litzler PY; Bauer F; Cribier A
Am J Cardiol; 2015 Apr; 115(8):1116-22. PubMed ID: 25726383
[TBL] [Abstract][Full Text] [Related]
26. Direct transcatheter aortic valve implantation with self-expandable bioprosthesis: feasibility and safety.
Fiorina C; Maffeo D; Curello S; Lipartiti F; Chizzola G; D'Aloia A; Adamo M; Mastropierro R; Gavazzi E; Ciccarese C; Chiari E; Ettori F
Cardiovasc Revasc Med; 2014 Jun; 15(4):200-3. PubMed ID: 24746865
[TBL] [Abstract][Full Text] [Related]
27. Severe intraprosthetic regurgitation and valve embolization after transcatheter aortic valve implantation.
Ben-Dor I; Satler LF; Pichard AD; Waksman R
Catheter Cardiovasc Interv; 2013 Feb; 81(2):392-6. PubMed ID: 22566389
[TBL] [Abstract][Full Text] [Related]
28. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of contrast injection during balloon aortic valvuloplasty before transcatheter aortic valve replacement: a pilot study.
Barbanti M; Sgroi C; Immè S; Aruta P; Deste W; Gulino S; Cannata S; Giarratana A; Bottari V; Giannazzo D; Garretto V; Patanè M; Benvenuto E; Capodanno D; Tamburino C
EuroIntervention; 2014 Jun; 10(2):241-7. PubMed ID: 24334876
[TBL] [Abstract][Full Text] [Related]
30. Incidence, predictive factors and haemodynamic consequences of acute stent recoil following transcatheter aortic valve implantation with a balloon-expandable valve.
Nombela-Franco L; Ribeiro HB; Urena M; Pasian S; Allende R; Doyle D; Delarochellière R; Delarochellière H; Laflamme L; Laflamme J; Jerez-Valero M; Côté M; Pibarot P; Larose E; Dumont E; Rodés-Cabau J
EuroIntervention; 2014; 9(12):1398-406. PubMed ID: 24064535
[TBL] [Abstract][Full Text] [Related]
31. Impact of balloon post-dilation on clinical outcomes after transcatheter aortic valve replacement with the self-expanding CoreValve prosthesis.
Barbanti M; Petronio AS; Capodanno D; Ettori F; Colombo A; Bedogni F; De Marco F; De Carlo M; Fiorina C; Latib A; Testa L; Bruschi G; Poli A; Giannini C; Curello S; Maffeo D; Sgroi C; Martina P; Gulino S; Patanè M; Ohno Y; Attizzani GF; Immè S; Cannata S; Gentili A; Rossi A; Tamburino C
JACC Cardiovasc Interv; 2014 Sep; 7(9):1014-21. PubMed ID: 25234674
[TBL] [Abstract][Full Text] [Related]
32. Transcatheter aortic valve implantation: anesthetic considerations.
Billings FT; Kodali SK; Shanewise JS
Anesth Analg; 2009 May; 108(5):1453-62. PubMed ID: 19372319
[TBL] [Abstract][Full Text] [Related]
33. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT.
Yang TH; Webb JG; Blanke P; Dvir D; Hansson NC; Nørgaard BL; Thompson CR; Thomas M; Wendler O; Vahanian A; Himbert D; Kodali SK; Hahn RT; Thourani VH; Schymik G; Precious B; Berger A; Wood DA; Pibarot P; Rodés-Cabau J; Jaber WA; Leon MB; Walther T; Leipsic J
JACC Cardiovasc Interv; 2015 Mar; 8(3):462-471. PubMed ID: 25790764
[TBL] [Abstract][Full Text] [Related]
34. Valve prosthesis distortion after cardiac compression in a patient who underwent transcatheter aortic valve implantation (TAVI).
Kim EK; Choi SH; Song PS; Park SJ
Catheter Cardiovasc Interv; 2014 Feb; 83(3):E165-7. PubMed ID: 22431325
[TBL] [Abstract][Full Text] [Related]
35. Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing.
Patsalis PC; Al-Rashid F; Neumann T; Plicht B; Hildebrandt HA; Wendt D; Thielmann M; Jakob HG; Heusch G; Erbel R; Kahlert P
JACC Cardiovasc Interv; 2013 Sep; 6(9):965-71. PubMed ID: 24050862
[TBL] [Abstract][Full Text] [Related]
36. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry.
Staubach S; Franke J; Gerckens U; Schuler G; Zahn R; Eggebrecht H; Hambrecht R; Sack S; Richardt G; Horack M; Senges J; Steinberg DH; Ledwoch J; Fichtlscherer S; Doss M; Wunderlich N; Sievert H;
Catheter Cardiovasc Interv; 2013 Feb; 81(2):348-55. PubMed ID: 22566406
[TBL] [Abstract][Full Text] [Related]
37. Edwards SAPIEN 3 valve.
Binder RK; Rodés-Cabau J; Wood DA; Webb JG
EuroIntervention; 2012 Sep; 8 Suppl Q():Q83-7. PubMed ID: 22995118
[TBL] [Abstract][Full Text] [Related]
38. Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height.
De Torres-Alba F; Kaleschke G; Diller GP; Vormbrock J; Orwat S; Radke R; Reinke F; Fischer D; Reinecke H; Baumgartner H
JACC Cardiovasc Interv; 2016 Apr; 9(8):805-813. PubMed ID: 27017367
[TBL] [Abstract][Full Text] [Related]
39. Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience.
Diemert P; Lange P; Greif M; Seiffert M; Conradi L; Massberg S; Blankenberg S; Reichenspurner H; Hagl C; Schmitz C; Schröfel H; Treede H; Schymik G; Kupatt C
Clin Res Cardiol; 2014 Mar; 103(3):183-90. PubMed ID: 24249313
[TBL] [Abstract][Full Text] [Related]
40. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
